Actively Recruiting
A Study Regarding Tissue Response During and After Treatment for Anal Cancer
Led by Sahlgrenska University Hospital · Updated on 2025-03-18
400
Participants Needed
2
Research Sites
313 weeks
Total Duration
On this page
Sponsors
S
Sahlgrenska University Hospital
Lead Sponsor
G
Göteborg University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to improve the understanding for the tumour biology in relation to treatment response in patients with anal cancer by examining: * The tumour microenvironment * The localisation of and cellular interactions between the tumour and immune cells * The gene and protein expression by cells present in the tumour and surrounding tissue.
CONDITIONS
Official Title
A Study Regarding Tissue Response During and After Treatment for Anal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Newly diagnosed or recurrent anal cancer
You will not qualify if you...
- No diagnosis of anal cancer
- Contraindication to biopsies and blood samples
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Gothenburg, Sweden, SE 416 85
Actively Recruiting
2
Sahlgrenska University Hospital
Gothenburg, Sweden
Actively Recruiting
Research Team
E
Eva Angenete PI, Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here